Please directly access your account by clicking RealCME Health Professional and use the same email address to log in to your account that you have used with EpocratesCME. For security purposes, you will be asked to establish a new password.
The RA Patient With Multiple Treatment Failures
The RA Patient With Multiple Treatment Failures
|Relevant Terms:||Rheumatoid Arthritis|
|Primary Audience:||Rheumatologists, Rheumatology Nurses|
|Credits:||0.75 AMA PRA Category 1 Credit™
0.75 ANCC contact hour
1 CA-BRN contact hour
|Expiration Date:||The accreditation for this activity has expired.|
|Curriculum Name:||Managing a Non-Responder to Methotrexate|
After completing this activity, the participant will demonstrate the ability to:
- Implement evidence-based guidelines into practice as warranted for the treatment of specific subsets of patients with rheumatoid arthritis (RA)
- Implement and/or optimize the utilization of target-based patient management within the next 3 months to standardize patient care and optimize overall outcomes
- Participants must review the materials on accreditation information, target audience, learning objectives, and disclosure information.
- Complete the entire activity, pre/post-test and evaluation.
- After passing the post-test, print out your electronic CE certificate.
- In order to successfully complete this activity learners must achieve a minimum of 65% on the post-test.
This activity is sponsored by the Institute for Continuing Healthcare Education
Release Date: September 24, 2013
Expiration Date: September 24, 2014
The Institute for Continuing Healthcare Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The Institute for Continuing Healthcare Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity offers 0.75 contact hours to participating nurses. This credit may be applied toward licensure requirements in those states that recognize American Nurses Credentialing Center's Commission on Accreditation (ANCC-COA) accredited providers.
Accreditation applies solely to educational activities and does not imply approval or endorsement of any commercial product by the ANCC-COA.
The Institute for Continuing Healthcare Education is approved by the California Board of Registered Nursing, Provider Number 13313. The Institute for Continuing Healthcare Education approves this activity for 1.0 contact hours.
California Pacific Medical Center
San Francisco, CA
Dr. Birnbaum has disclosed the following relevant financial relationships in the past 12 months: Janssen, Amgen, Pfizer,& Abbott/PE.
Vivian Bykerk, MD
Hospital for Special Surgery
New York, NY
Dr. Bykerk has disclosed the following relevant financial relationships that have occurred within the past 12 months: Amgen, Antares, Astellas, BMS, Genentech, Merck, and UCB/A, Novartis,/SS.
Jacqueline M. Fritz, RN, MSN, CSN
Medical Advancement Center
Ms. Fritz has disclosed the following relevant financial relationships that has occurred within the past 12 months: Institute for Continuing Healthcare Education and UCB/A; Amgen, UCB, Genentech, Johnson & Johnson, Savient/SB; Amgen, UCB, Genentech, Johnson & Johnson, Savient/PE.
Eve Wilson, PhD, CCMEP, ELS
Morphos Medical Education, LLC
Dr. Wilson has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.
Stanford Peng, MD
Virginia Mason Medical Center
Dr. Peng has disclosed that he does not have any relevant financial relationships specific to the subject matter of the content of this activity.
Activity Development and Management Team
Off-label Product Disclosure
This educational activity includes discussion of published and/or investigational uses of agents that are not indicated by the U.S. Food and Drug Administration. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
COURSE VIEWING REQUIREMENTS
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 18.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 13.0+ for Windows, Mac OS, or Linux
Safari 4.0+ for Mac OSX 10.5 and above
|Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
For additional technical support, please send an email to firstname.lastname@example.org.
General Disclosure and Copyright Statement
This information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a healthcare professional regarding diagnostic and treatment options of a specific patient's medical condition. In no event will the Institute be responsible for any decision made or action taken based upon the information provided in this activity.
Participants are encouraged to consult the package insert for all products for updated information and changes regarding indications, dosages, and contraindications. This recommendation is particularly important for new or infrequently used products.
Copyright 2013. Institute for Continuing Healthcare Education (the Institute). All rights reserved. No part of this publication may be reproduced or transmitted in any other form or by any means electronic or mechanical—without first obtaining written permission from the Institute.